Beijing Gobroad Boren Hospital - China’s Leading CAR-T & Cell Therapy Center | CancerCareE

Beijing Gobroad Boren Hospital

China’s Largest Private CAR-T & Cellular Immunotherapy Hospital | Official Site for Yescarta & Carteyva

Opened: 2020 Beds: 300+ CAR-T Approved GMP Cell Lab

Hospital Overview

Beijing Gobroad Boren Hospital, part of Gobroad Healthcare Group, is China’s first and largest private hospital fully dedicated to cellular immunotherapy and precision oncology. Opened in 2020, it is one of the few hospitals in China officially authorized to administer commercial CAR-T therapies (Fosun Kite’s Yescarta and JW Therapeutics’ Relmacabtagene/Carteyva).

300+
Beds
1,000+
CAR-T Cases Annually
50+
Countries Served
10K+m²
GMP Facility

Milestones

  • First private hospital in China focused on cell therapy
  • Authorized center for Yescarta (axicabtagene ciloleucel)
  • Authorized center for Relmacabtagene (Carteyva)
  • One of the highest CAR-T volumes worldwide

Accreditations & Capabilities

  • NRDL reimbursement for both CAR-T products
  • Large in-house GMP cell manufacturing lab
  • Specialized hematology & lymphoma departments

CAR-T & Cellular Therapy Expertise

Approved CAR-T Therapies

  • Yescarta (Axicabtagene ciloleucel) – Fosun Kite
  • Relmacabtagene autoleucel (Carteyva) – JW Therapeutics
  • Both on China’s National Reimbursement Drug List (NRDL)

Indications & Experience

  • Relapsed/refractory large B-cell lymphoma
  • Follicular lymphoma
  • Mantle cell lymphoma (selected products)
  • Extensive experience managing CRS & neurotoxicity

Additional Advanced Therapies

  • TIL therapy clinical trials
  • NK & CIK cell therapy
  • Universal CAR-T & next-generation products

Available Advanced Treatments

TreatmentAvailability
CAR-T Therapy (Yescarta)✓ (Official Center)
CAR-T Therapy (Carteyva)✓ (Official Center)
TIL Therapy✓ (Clinical Trials)
NK / CIK Cell Therapy
Precision Oncology & NGS

Why International Patients Choose Gobroad Boren

Clinical Leadership

  • Highest CAR-T volume in Chinese private sector
  • Expert team trained in US/Europe
  • Excellent safety & efficacy outcomes

Dramatic Cost Advantage

  • CAR-T price after NRDL: ~$40,000–60,000 USD
  • 70–90% lower than USA/Europe

International Patient Support

  • Arabic, Russian, English, French coordinators
  • Visa invitation, airport transfer, accommodation
  • Fast-track evaluation & infusion

Contact & Location

Address

Building 1, No. 6 Yard, Zhuyuan Road
Shunyi District, Beijing 101318, China

International Patients

Phone: +86-010-58206666
WhatsApp: +86 186 1174 1613
Email: international@gobroadhealthcare.com

Available in Other Languages

For Persian Speakers

Visit our Persian website for information in Farsi:

cartcelltherapy.ir

Ready for CAR-T Therapy at Gobroad Boren Beijing?

Get free evaluation, cost quote, and treatment plan from China’s leading CAR-T center.

Request Free Consultation

Leave a Reply

Your email address will not be published. Required fields are marked *